A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT06540066 · TERMINATED

Trial details

NCT number: NCT06540066
Sponsor: BeiGene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Advanced Solid Tumor Metastatic Cancer Metastatic Solid Tumor

Start date: 2024-09-11
Primary completion: 2026-01-09
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.